Semax is a synthetic ACTH(4-10) analog studied in laboratory research for its interaction with BDNF and NGF signaling pathways and its modulation of serotonergic and dopaminergic neurotransmission.
For laboratory research use only. Not for human or veterinary use.
Semax is a synthetic heptapeptide based on an ACTH fragment and a Pro-Gly-Pro sequence. Published research has examined its relationship to neurotrophin signaling in experimental models. This 10 mg vial is supplied for laboratory research only.
Preclinical studies have examined Semax in relation to BDNF and NGF expression and associated signaling pathways. Results from experimental models should not be presented as established effects in people.
| Total Content | Volume | Concentration | 0.1 mL | 0.2 mL | 0.4 mL | 1.0 mL |
|---|---|---|---|---|---|---|
| 10mg | 3ml | 3.33mg/mL | 0.33mg | 0.67mg | 1.33mg | 3.33mg |
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Tested for potency, purity, and identity verification. COA generated for the current production batch.
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
It is the total Semax content in the vial. The concentration depends on the final volume selected for laboratory analysis.
Published preclinical studies have examined BDNF and NGF expression and related signaling pathways. These findings describe research areas, not a product benefit or human-use claim.
Use the storage conditions provided on the label and in the current lot documentation. Exact storage conditions and stability periods should be based on product-specific information.
